[
    {
        "Header Number": "N/A",
        "Title": "12912_Cover Page_SAP",
        "Content": "",
        "Sub-sections": []
    },
    {
        "Header Number": "N/A",
        "Title": "SAP 12912 V1.0 20Mar2018_Redacted final_13NOV2018",
        "Content": "",
        "Sub-sections": [
            {
                "Header Number": "N/A",
                "Title": "Title Page",
                "Content": " Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men increase the Risk for the Development of Non-arteriticAnterior Ischemic Optic Neuropathy (NAION) [NAION]Bayer study drugBAY 38-9456/vardenfil/Levitra Study purpose:Post Marketing Follow-up studyClinical study phase:IVDate:20 March 2018Study No.:12912Version:1.0Author: ConfidentialThe information provided in this document is strictly confidential and is intended solely for the guidance of the clinical investigation.  Reproduction or disclosure of this document, whether in part or in full, to parties not associated with the clinical investigation or its use for any other purpose without the prior written consent of the sponsor is not permitted.Throughout this document, symbols indicating proprietary names (\u00ae, TM) are not displayed.  Hence, the appearance of product names without these symbols does not imply that these names are not protected.This Statistical Analysis Plan is produced on a word-processing system and bears no signatures.The approval of the Statistical Analysis Plan is documented in a separate Signature Document.PPDStatistical Analysis PlanProtocol No.: BAY 38-9456/12912Page: 2 of 8",
                "Sub-sections": []
            },
            {
                "Header Number": "N/A",
                "Title": "Table of Contents",
                "Content": "Title Page................................................................................................................................... 1Abbreviations............................................................................................................................ 31.Introduction ....................................................................................................................... 42.Study Objectives................................................................................................................ 43.Study Design ...................................................................................................................... 44.General Statistical Considerations .................................................................................. 54.1General Principles............................................................................................................ 54.2Handling of Dropouts ...................................................................................................... 54.3Handling of Missing Data................................................................................................ 64.4Interim Analyses and Data Monitoring............................................................................ 64.5Data Rules........................................................................................................................ 64.6Blind Review ................................................................................................................... 65.Analysis Sets....................................................................................................................... 76.Statistical Methodology..................................................................................................... 76.1Population characteristics ................................................................................................ 86.2Efficacy............................................................................................................................ 86.3Pharmacokinetics/pharmacodynamics............................................................................. 86.4Safety ............................................................................................................................... 87.Document history and changes in the planned statistical analysis ............................... 88.References .......................................................................................................................... 8Statistical Analysis PlanProtocol No.: BAY 38-9456/12912Page: 3 of 8",
                "Sub-sections": []
            },
            {
                "Header Number": "N/A",
                "Title": "Abbreviations",
                "Content": "AEAdverse eventCIConfidence IntervalCSREDClinical Study ReportErectile DysfunctionLOSListing only setMedDRAMedical Dictionary for Regulatory ActivitiesN/ANAIONPDE5Not applicableNon-Arteritic Ischemic Optic NeuropathyPhosphodiesterase type 5 PPSPer-protocol setPTPerferred TermSAESerious adverse eventSOCSystem Organ ClassSAPStatistical Analysis Plan",
                "Sub-sections": []
            },
            {
                "Header Number": "1.",
                "Title": "Introduction",
                "Content": "",
                "Sub-sections": []
            },
            {
                "Header Number": "2.",
                "Title": "Study Objectives",
                "Content": "",
                "Sub-sections": []
            },
            {
                "Header Number": "3.",
                "Title": "Study Design",
                "Content": "",
                "Sub-sections": [
                    {
                        "Header Number": "N/A",
                        "Title": "Figure 3\u20131\uff1aStudy Design",
                        "Content": "",
                        "Sub-sections": []
                    }
                ]
            },
            {
                "Header Number": "4.",
                "Title": "General Statistical Considerations",
                "Content": "",
                "Sub-sections": [
                    {
                        "Header Number": "4.1",
                        "Title": "General Principles",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "4.2",
                        "Title": "Handling of Dropouts",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "4.3",
                        "Title": "Handling of Missing Data",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "4.4",
                        "Title": "Interim Analyses and Data Monitoring",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "4.5",
                        "Title": "Data Rules",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "4.6",
                        "Title": "Blind Review",
                        "Content": "",
                        "Sub-sections": []
                    }
                ]
            },
            {
                "Header Number": "5.",
                "Title": "Analysis Sets",
                "Content": "",
                "Sub-sections": []
            },
            {
                "Header Number": "6.",
                "Title": "Statistical Methodology",
                "Content": "",
                "Sub-sections": [
                    {
                        "Header Number": "6.1",
                        "Title": "Population characteristics",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "6.2",
                        "Title": "Efficacy",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "6.3",
                        "Title": "Pharmacokinetics/pharmacodynamics",
                        "Content": "",
                        "Sub-sections": []
                    },
                    {
                        "Header Number": "6.4",
                        "Title": "Safety",
                        "Content": "",
                        "Sub-sections": []
                    }
                ]
            },
            {
                "Header Number": "7.",
                "Title": "Document history and changes in the planned statistical analysis",
                "Content": "",
                "Sub-sections": []
            },
            {
                "Header Number": "8.",
                "Title": "References",
                "Content": "",
                "Sub-sections": []
            }
        ]
    }
]